v1
Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial.
- NobleID
- NI6P05W76R50S83
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/C39CF522
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims